The Last Watchdog
APRIL 16, 2019
based life sciences and high-tech manufacturing companies sheds light on how digital transformation – and the rising role of third-party partners – have combined to create unprecedented operational challenges in the brave new world of digital commerce. A recent poll of some 300 senior executives from U.S.-based
IBM Big Data Hub
MAY 9, 2024
A study conducted by the Journal of the American Medical Association (JAMA) revealed that errors were found in the records of one-fifth of patients with access to ambulatory care notes. It’s worth noting that these regulations don’t just apply to patient care-focused organizations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
eSecurity Planet
APRIL 21, 2022
When determining what changes will help a company without flooding their security team with false alerts that waste time and money, the fundamental consideration should be to deeply study the organization and understand the answers to three basic questions: What should never happen? What should be expected all of the time?
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. Some considerations in making that assessment: Is the company a provider of health care? Clinical Trial Exemption.
IBM Big Data Hub
AUGUST 11, 2023
Manufacturing execution systems (MES) have grown in popularity across the manufacturing industry. If your manufacturing processes have become more intricate and challenging to manage manually, an MES can help streamline manufacturing operations management, increase efficiency and reduce errors.
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. Some considerations in making that assessment: Is the company a provider of health care? Clinical Trial Exemption.
HL Chronicle of Data Protection
OCTOBER 8, 2018
Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers. Some considerations in making that assessment: Is the company a provider of health care? Clinical Trial Exemption.
Expert insights. Personalized for you.
133 
Let's personalize your content